# OnCo record paper-shaw-alk-resistance-mutations-lorlatinib-jco-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: .
@prefix onco: .
@prefix xsd: .
a schema:ScholarlyArticle ;
onco:kind "paper" ;
schema:identifier "paper-shaw-alk-resistance-mutations-lorlatinib-jco-2019" ;
schema:name "ALK resistance mutations and efficacy of lorlatinib in advanced anaplastic lymphoma kinase-positive non-small-cell lung cancer"@en ;
schema:description "In patients whose cancer had already outgrown a second ALK drug, the third-generation drug worked in seven out of ten of those whose tumour carried a resistance mutation and in fewer than three out of ten of those whose tumour did not."@en ;
schema:url ;
schema:dateModified "2026-09-25"^^xsd:date ;
schema:citation , ;
schema:sameAs ;
schema:datePublished "2019"^^xsd:gYear ;
schema:author "Shaw AT, Solomon BJ, Besse B, et al." ;
onco:related ;
onco:cancers ;
onco:technologies , , ;
onco:targets , ;
onco:drugs , , ;
onco:institutions ;
onco:pathways , ;
onco:terms , , ;
onco:people ;
onco:journals .